| Association of Genetic Liability to Allergic Diseases with Overall and Early-Onset Colorectal Cancer Risk: A Mendelian Randomization Study. |
39982694 |
Cancer Epidemiol Biomarkers Prev |
| Cancer Detection in Breast MRI Screening via Explainable AI Anomaly Detection. |
40662973 |
Radiology |
| Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study. |
26319120 |
Breast Cancer Res Treat |
| CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer. |
35483965 |
J Nucl Med |
| Characterization of Additive Gene-environment Interactions For Colorectal Cancer Risk. |
39316822 |
Epidemiology |
| Data gaps and opportunities for modeling cancer health equity. |
37947335 |
J Natl Cancer Inst Monogr |
| Dermcidin expression is associated with disease progression and survival among breast cancer patients. |
24562771 |
Breast Cancer Res Treat |
| Designing early detection programs for ovarian cancer. |
22180403 |
Ann Oncol |
| Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study. |
22903690 |
Breast Cancer Res Treat |
| Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study. |
27745870 |
Surgery |
| Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility? |
27001493 |
Clin Chem |
| Establishing an Evidence-based Modern Breast MRI Program. |
41671073 |
J Breast Imaging |
| Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125. |
22155417 |
Gynecol Oncol |
| Identifying post-menopausal women at elevated risk for epithelial ovarian cancer. |
26343159 |
Gynecol Oncol |
| Immunity to placental malaria. III. Impairment of interleukin(IL)-12, not IL-18, and interferon-inducible protein-10 responses in the placental intervillous blood of human immunodeficiency virus/malaria-coinfected women. |
11756993 |
J Infect Dis |
| Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening. |
22750949 |
Cancer Prev Res (Phila) |
| Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer. |
22962406 |
Cancer Epidemiol Biomarkers Prev |
| Investigating the causal effect of potential therapeutic agents for colorectal cancer prevention: a Mendelian randomization analysis. |
41085561 |
Cancer Epidemiol Biomarkers Prev |
| JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors. |
24764577 |
Cancer Immunol Res |
| Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. |
23248253 |
J Clin Oncol |
| Multiparametric MRI Markers Associated with Breast Cancer Risk in Women with Dense Breasts. |
41374973 |
Cancers (Basel) |
| Potential role of HE4 in multimodal screening for epithelial ovarian cancer. |
21917606 |
J Natl Cancer Inst |
| Protein and glycomic plasma markers for early detection of adenoma and colon cancer. |
27821646 |
Gut |
| Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections with Obesity. |
27769113 |
J Proteome Res |
| Recommendation to use exact P-values in biomarker discovery research in place of approximate P-values. |
30099328 |
Cancer Epidemiol |
| Sex hormones and risk of lung and colorectal cancers in women: a Mendelian randomization study. |
38659935 |
Res Sq |
| The Future of Quantitative Breast Imaging: Integrated to Integral Imaging Biomarkers for Precision Cancer Care, From the <i>AJR</i> Special Series on Quantitative Imaging. |
42089524 |
AJR Am J Roentgenol |
| Validation of Fully-Automated Deep Learning-Based Fibroglandular Tissue Segmentation for Efficient and Reliable Quantitation of Background Parenchymal Enhancement in Breast MRI. |
41293527 |
ArXiv |
